EverSource Wealth Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.4K Buy
2,167
+1,845
+573% +$41.5K ﹤0.01% 1965
2025
Q4
$7.41K Buy
322
+298
+1,242% +$9.8K ﹤0.01% 2941
2025
Q3
$722 Sell
24
-335
-93% -$10K ﹤0.01% 3845
2025
Q2
$13.1K Buy
359
+321
+845% +$11.6K ﹤0.01% 2627
2025
Q1
$1.38K Buy
38
+25
+192% +$1.04K ﹤0.01% 3103
2024
Q4
$547 Buy
+13
New +$645 ﹤0.01% 3159
2023
Q3
Sell
-25
Closed -$1.15K 2640
2023
Q2
$1.15K Sell
25
-12
-32% -$557 ﹤0.01% 2170
2023
Q1
$1.48K Buy
+37
New +$1.59K ﹤0.01% 2024
2022
Q3
Sell
-16
Closed 2099
2022
Q2
$0 Sell
16
-69
-81% -$4.25K ﹤0.01% 1860
2022
Q1
$7K Sell
85
-66
-44% -$4.59K ﹤0.01% 1144
2021
Q4
$13K Buy
+151
New +$12.3K ﹤0.01% 863

Other funds holding RARE